22 dec: BICHELS WEEKENDHAPSERE - OGSÅ I JULEN
23 dec: Top 3 på teamudvikling
22-12-2010 16:57:00

Briscoe Law Firm Investigates Martek Biosciences for Shareholders

The

Briscoe Law Firm, PLLC, founded by a former state prosecutor and

enforcement attorney for the United States Securities and Exchange

Commission, and the law firm of Powers

Taylor LLP are investigating the fairness of the proposed

acquisition of Martek

Biosciences Corporation (“Martek Biosciences” or “MATK”) (NASDAQ:

MATK) by Royal DSM N.V. (“DSM”) for shareholders. The investigation

relates to possible breaches of fiduciary duty and other violations of

state law by the Board of Directors of Martek Biosciences for approving

this transaction, whether Martek Biosciences’ Board of Directors acted

in the shareholders’ best interests, and whether the transaction

provides fair value and adequate disclosures to the shareholders.

The definitive acquisition agreement, which was announced on December

21, 2010, involves an all-cash tender offer valued at approximately

$1.09 billion that is expected to commence in January 2011 and close in

February 2011. Under the proposed acquisition, Martek Biosciences

shareholders will receive a cash payment of only $31.50 for each share

of Martek Biosciences/MATK common stock they hold. While the acquisition

price reportedly represents an approximate 35% premium over Martek

Biosciences’ closing price the day before the acquisition announcement,

Martek Biosciences recently reported strong fourth quarter results,

including a 36% increase in revenue growth, well above analysts’

estimates, and operational improvements. Based on this and other

factors, the firms believe that the acquisition price significantly

undervalues the company and may not be fair to Martek Biosciences

shareholders.

If you currently own shares of Martek Biosciences/MATK and would like

additional information regarding this investigation, or if you have

information regarding the allegations involved in this transaction,

please contact Patrick Powers at Powers Taylor LLP, toll free (877)

728-9607, via e-mail at patrick@powerstaylor.com,

or Willie Briscoe at The Briscoe Law Firm, PLLC toll free (877)

397-5991, or via email at WBriscoe@TheBriscoeLawFirm.com.

There is no cost or fee to you.

The Briscoe Law Firm is a full service business litigation and

shareholder rights advocacy firm with more than 20 years of experience

in complex litigation and transactional matters.

Powers Taylor LLP is a boutique litigation law firm that handles a

variety of complex business litigation matters, including claims of

investor and stockholder fraud, shareholder oppression, shareholder

derivative suits, and security class actions.

Powers Taylor LLP

Patrick Powers, 877-728-9607

patrick@powerstaylor.com

or

The

Briscoe Law Firm, PLLC

Willie Briscoe, 877-397-5991

WBriscoe@TheBriscoeLawFirm.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
26 jul
 
Pouli,   Forum er i den grad domineret af børn, studerende, ludomaner, buffet-wannabees and what hav..
24
28 jul
GEN
Der er lidt nyt fra Morphosys angående deres CD38 antistof - det lader heldigvis til at gå lidt lang..
17
14:02
 
Jeg er helt vild med vendingen "og investere mine penge i aktier ud fra en strategi jeg mener vil sl..
12
28 jul
 
Dejligt at der er nogen som kan svare "sobert" på et stillet spørgsmål.   Svaret kan indeholde ironi..
12
24 jul
OMXN40
Det bliver/er hverdagskost i alle europæiske lande inden længe.. Men tankevækkende, at terrortruslen..
12
25 jul
EXQ
Så lykkedes det at komme til Vedbæk for at besøge Exiqon. Damen, en kammerat og jeg selv blev taget ..
11
27 jul
 
Jeg har opdateret mine udbyttelister med tilbagekøb.   http://www.proinvestor.com/boards/69564/    
10
29 jul
FING-B
XO/Sologstrand, Mackeith, Vildum, Swiftnick og andre FING-skeptikere   1) Er vi enige i, at markedet..
9
29 jul
BIOPOR
I er tydeligvis enormt begavede og succesfulde alle tre. Men kunne det være muligt for jer at måle j..
9
28 jul
VELO
28/07/2014 08:30:00 - OMX Copenhagen, News     VELO: Veloxis Pharmaceuticals A/S - Envarsus ® får ..
9

Mærsk/SEB: Skimter en bedring i containermarkedet

30-07-2014 15:35:46
Det pressede marked for containerfragt har været en af de større sten i skoene for A.P. Møller - Mærsk siden finanskrisen i 2008-2009, men nu er der tegn på, at..

Vestas-storkunde presset af lavere energipriser

30-07-2014 13:05:00
Portugisiske EDPR, der er verdens fjerdestørste vindparkejer og storkunde hos Vestas, oplevede i første halvår et pres på indtjeningen som følge af faldende els..

Aktier/middag: Genmab og DSV ligger i top

30-07-2014 11:40:48
DSV fortsætter tirsdag de gode takter fra morgenen efter et positivt regnskab i et marked, der generelt set stiger svagt. Genmab har ligeledes momentum.Efter at..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
AaB-aktie sendt i kurshop af tegningsretter
2
Aktier/tendens: DSV kan køre fra markedet
3
Aktier/middag: Genmab og DSV ligger i top
4
Auriga: Stærk underliggende fremgang hos mastodonten Bayer
5
Vestas-storkunde presset af lavere energipriser
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
30. juli 2014 19:11:27
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140723.1 - EUROWEB6 - 2014-07-30 19:11:27 - 2014-07-30 19:11:27 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x